T1	Intervention 422 550	Subjects in the treatment group received 2.0 clinical units of secretin per kilogram of body weight as a single intravenous dose
T2	Intervention 552 746	Subjects in the placebo group received normal saline solution. Neurodevelopmental and behavioral assessments were performed for all subjects before injection and at 3 and 6 weeks after injection
